Freedom Labs & Diagnostics LLC

Freedom Labs & Diagnostics LLC was paid $69K by Medicaid between Jun 2021 and Jan 2024, across 37 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 34% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Nevada

Rank by total paid#21 of 31

Median peer was paid$269K

This provider vs. median0.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	3,083	$12K
2022	3,124	$13K
2023	3,633	$38K
2024incomplete	1,086	$6K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	34%	1,025	699	$23K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	32%	834	308	$22K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	5.1%	67	51	$3K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	3.3%	305	195	$2K
87640		2.5%	281	98	$2K
87486		2.5%	268	93	$2K
87581		2.5%	268	93	$2K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	2.5%	273	94	$2K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	2.4%	293	108	$2K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	2.3%	384	253	$2K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	1.8%	72	39	$1K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	1.6%	706	455	$1K

25 more codes

80061	Lipid panel	1.1%	605	$786.04
83036	Hemoglobin; glycosylated (A1C)	<1%	644	$587.42
80053	Comprehensive metabolic panel	<1%	910	$504.70
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	286	$407.07
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	692	$398.82
87529		<1%	20	$335.16
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	843	$323.91
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	47	$295.74
84439		<1%	328	$233.70
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	20	$191.52
84443	Thyroid stimulating hormone (TSH)	<1%	559	$183.52
82746		<1%	45	$170.51
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	20	$167.51
87511		<1%	20	$143.64
82607		<1%	67	$113.08
83540		<1%	47	$70.02
86140		<1%	41	$49.42
83735		<1%	22	$41.13
81001		<1%	172	$32.40
81003		<1%	18	$4.59
84550		<1%	33	$3.08
36415	Collection of venous blood by venipuncture	0%	33	$0.00
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	0%	470	$0.00
87631		0%	193	$0.00
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSAGA, RICK (OWNER)